OIA
TEVA icon

Optimum Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Optimum Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$358K Buy
17,715
+17,475
+7,281% +$307K 0.14% 130
2025
Q2 		$4.02K Hold
240
– – ﹤0.01% 559
2025
Q1 		$3.69K Hold
240
– – ﹤0.01% 576
2024
Q4 		$5.29K Hold
240
– – ﹤0.01% 552
2024
Q3 		$4.33K Hold
240
– – ﹤0.01% 579
2024
Q2 		$3.9K Hold
240
– – ﹤0.01% 574
2024
Q1 		$3.39K Hold
240
– – ﹤0.01% 585
2023
Q4 		$2.51K Hold
240
– – ﹤0.01% 580
2023
Q3 		$2.45K Hold
240
– – ﹤0.01% 643
2023
Q2 		$1.81K Sell
240
-2,800
-92% -$22.7K ﹤0.01% 653
2023
Q1 		$26.9K Buy
3,040
+800
+36% +$7.91K 0.01% 444
2022
Q4 		$20.4K Buy
2,240
+2,000
+833% +$17.5K 0.01% 484
2022
Q3 		$2K Hold
240
– – ﹤0.01% 742
2022
Q2 		$2K Hold
240
– – ﹤0.01% 765
2022
Q1 		$2K Hold
240
– – ﹤0.01% 794
2021
Q4 		$2K Hold
240
– – ﹤0.01% 787
2021
Q3 		$2K Hold
240
– – ﹤0.01% 801
2021
Q2 		$2K Hold
240
– – ﹤0.01% 870
2021
Q1 		$3K Hold
240
– – ﹤0.01% 853
2020
Q4 		$2K Sell
240
-500
-68% -$4.79K ﹤0.01% 838
2020
Q3 		$7K Sell
740
-400
-35% -$4.23K ﹤0.01% 739
2020
Q2 		$14K Sell
1,140
-1,000
-47% -$11.3K ﹤0.01% 655
2020
Q1 		$19K Buy
2,140
+400
+23% +$4.1K 0.01% 586
2019
Q4 		$17K Sell
1,740
-100
-5% -$893 0.01% 702
2019
Q3 		$13K Sell
1,840
-1,113
-38% -$8.53K ﹤0.01% 746
2019
Q2 		$27K Hold
2,953
– – 0.01% 629
2019
Q1 		$46K Sell
2,953
-200
-6% -$3.53K 0.02% 522
2018
Q4 		$49K Sell
3,153
-375
-11% -$7.69K 0.02% 482
2018
Q3 		$76K Sell
3,528
-376
-10% -$8.73K 0.02% 450
2018
Q2 		$95K Hold
3,904
– – 0.03% 409
2018
Q1 		$67K Buy
+3,904
New +$76.2K 0.02% 479
2017
Q3 		– Sell
-8,638
Closed -$287K – 308
2017
Q2 		$287K Sell
8,638
-630
-7% -$19.5K 0.1% 224
2017
Q1 		$297K Sell
9,268
-150
-2% -$5.12K 0.11% 221
2016
Q4 		$341K Sell
9,418
-201
-2% -$8.03K 0.13% 198
2016
Q3 		$443K Sell
9,619
-417
-4% -$21.8K 0.17% 173
2016
Q2 		$504K Sell
10,036
-1,204
-11% -$64.1K 0.2% 144
2016
Q1 		$601K Sell
11,240
-5,997
-35% -$352K 0.24% 126
2015
Q4 		$1.13M Buy
17,237
+2,532
+17% +$156K 0.44% 64
2015
Q3 		$830K Buy
+14,705
New +$953K 0.34% 90
2015
Q1 		$979K Sell
15,708
-680
-4% -$39.5K 0.31% 86
2014
Q4 		$942K Sell
16,388
-800
-5% -$44.6K 0.3% 89
2014
Q3 		$925K Sell
17,188
-1,000
-5% -$53K 0.31% 89
2014
Q2 		$953K Sell
18,188
-182
-1% -$9.3K 0.31% 89
2014
Q1 		$971K Sell
18,370
-376
-2% -$17.4K 0.36% 76
2013
Q4 		$751K Sell
18,746
-100
-0.5% -$3.94K 0.28% 102
2013
Q3 		$712K Buy
+18,846
New +$735K 0.29% 94

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Optimum Investment Advisors's TEVA Position: Q3 2025 in Review

Optimum Investment Advisors increased its Teva Pharmaceuticals (TEVA) stake by 7,281% in Q3 2025, buying an estimated $307K and bringing the position to 17,715 shares worth $358K. The position accounts for 0.14% of the portfolio, ranked #130.

Optimum Investment Advisors first reported a position in TEVA in Q3 2013 and has held it in 46 quarters since. The position peaked at $1.13M in Q4 2015. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Optimum Investment Advisors held 17,715 shares of Teva Pharmaceuticals worth $358K as of Q3 2025.
  • Optimum Investment Advisors bought 17,475 Teva Pharmaceuticals shares in Q3 2025, an estimated $307K.
  • Teva Pharmaceuticals made up 0.14% of Optimum Investment Advisors's portfolio in Q3 2025, its #130 holding.
  • Optimum Investment Advisors first reported a position in Teva Pharmaceuticals in Q3 2013 and has held it in 46 quarters since.
  • Optimum Investment Advisors's Teva Pharmaceuticals position peaked at $1.13M in Q4 2015.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.